Stay up-to-date on XOFLUZA

Sign up to receive the latest news, updates, and information about XOFLUZA and the flu.

By registering at this site, you certify that you are a healthcare professional licensed in the United States or its territories and are indicating that you wish to receive information about XOFLUZA, other Genentech products, and related disease education. Genentech's intent is to only provide information to healthcare professionals licensed in the United States or its territories who would likely be treating patients within the FDA-approved indications for this product.

Select
  • Alaska
  • Alabama
  • Arkansas
  • American Samoa
  • Arizona
  • California
  • Colorado
  • Connecticut
  • District Of Columbia
  • Delaware
  • Florida
  • Georgia
  • Guam
  • Hawaii
  • Iowa
  • Idaho
  • Illinois
  • Indiana
  • Kansas
  • Kentucky
  • Louisiana
  • Massachusetts
  • Maryland
  • Maine
  • Marshall Islands
  • Michigan
  • Minnesota
  • Missouri
  • Mississippi
  • Montana
  • North Carolina
  • North Dakota
  • Nebraska
  • New Hampshire
  • New Jersey
  • New Mexico
  • Nevada
  • New York
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Puerto Rico
  • Palau
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Virginia
  • Virgin Islands
  • Vermont
  • Washington
  • Wisconsin
  • West Virginia
  • Wyoming
Select
  • Family Medicine
  • Internal Medicine
  • Pediatrics
  • Emergency Medicine
  • Urgent Care Medicine
  • General Practice
  • Other
Select
  • Physician
  • Nurse Practitioner
  • Physician Assistant
  • Nurse
  • Pharmacist
  • Other

By registering at this site, you certify that you are a healthcare professional licensed in the United States or its territories and are indicating that you wish to receive information about XOFLUZA, other Genentech products, and related disease education. Genentech's intent is to only provide information to healthcare professionals licensed in the United States or its territories who would likely be treating patients within the FDA-approved indications for this product.

By completing and submitting this form, you agree to allow Genentech and its agents to collect the information provided and to be contacted by Genentech and its agents in the future regarding XOFLUZA, other Genentech products, and related disease education. Genentech will not sell, rent, or otherwise distribute your name and any personally identifiable information outside of Genentech and its agents. Genentech will only use your information in accordance with its Privacy Policy.

You've successfully registered

Thank you for signing up to receive information about XOFLUZA and the flu. You'll receive your first communication during the flu season.

Learn more about XOFLUZA by clicking here.